Apstatin
Apstatin is a potent aminopeptidase P (APP) inhibitor with Ki values of 2.6, 0.64 µM for rat and human APP, respectively. Apstatin shows cardioprotection.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 160470-73-5
- Fòrmula: C23H33N5O5
- Peso molecular:459.54
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
IC50: 2.6 µM (rat APP); 0.64 µM (human APP)[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MV4-11 | IC50 |
>20 μM
Compound: 3
|
Cytotoxicity against CASP1 knockout human MV4-11 cells assessed as reduction in cell viability incubated for 24 hrs by celltiter-glo assay
Cytotoxicity against CASP1 knockout human MV4-11 cells assessed as reduction in cell viability incubated for 24 hrs by celltiter-glo assay
|
[PMID: 36724486] |
| MV4-11 | IC50 |
>20 μM
Compound: 3
|
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability incubated for 24 hrs by celltiter-glo assay
Cytotoxicity against human MV4-11 cells assessed as reduction in cell viability incubated for 24 hrs by celltiter-glo assay
|
[PMID: 36724486] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:270-310 g, Male Wistar rats[1]
-
Dosage:1 mg/kg
-
Administration:I.v.; 5 min before ischaemia
-
Result:Significantly reduced infarct size (IS) in acute myocardial ischaemia.
Chemical Information
-
No. CAS 160470-73-5
-
Peso molecular 459.54
-
Fòrmula C23H33N5O5
-
SMILES
C[C@@H](C(N)=O)NC([C@H]1N(C([C@H]2N(C([C@@H](O)[C@H](N)CC3=CC=CC=C3)=O)CCC2)=O)CCC1)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Wolfrum S, et al. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. Br J Pharmacol. 2001 Sep;134(2):370-4. [Content Brief]
[2]. Maggiora LL, et al. Apstatin analogue inhibitors of aminopeptidase P, a bradykinin-degrading enzyme. J Med Chem. 1999 Jul 1;42(13):2394-402. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Apstatin Related Classifications
HY-128090 Related Classifications
Powered by Bioz